Denis Drygin
Nessuna posizione attualmente
Storia della carriera di Denis Drygin
Precedenti posizioni note di Denis Drygin
Società | Posizione | Inizio | Fine |
---|---|---|---|
REGULUS THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 03/08/2020 | 29/11/2022 |
Pimera, Inc.
Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Fondatore | 01/01/2013 | 31/07/2020 |
Corporate Officer/Principal | 01/01/2013 | 31/07/2020 | |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Formazione di Denis Drygin
University of Massachusetts | Doctorate Degree |
Moscow State University Lomonosov | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Russia | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Graduate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
REGULUS THERAPEUTICS INC. | Health Technology |
Aziende private | 2 |
---|---|
Pimera, Inc.
Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Finance |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Denis Drygin
- Esperienza